HVTN 077

A Phase 1B Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenoviral Subtype 35 (rAd35) and Subtype 5 (rAd5) HIV-1 Vaccines When Given as a Heterologous Prime-Boost Regimen or as Boosts to a Recombinant DNA Vaccine in Healthy, Ad5-Na?ve and Ad5-Exposed, Low Risk, HIV-1 Uninfected Adult Participants

Trial Details:

Ib Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) January 01, 2009
VRC-HIVDNA044-00-VP,VRC-HIVADV027-00-VP,VRC-HIVADV038-00-VP Ad5 env A; Ad35 Env A; DNA Env A
VRC-HIVADV027-00-VP Viral Vector - Adeno
VRC-HIVADV038-00-VP Viral Vector - Adeno
USA 192